Description

Ranexa 1000 (Ranolazine) Tablets with Prolonged Release 1000 mg. №60

Ingredients

Each tablet contains 1000 mg of ranolazine.

Dosage

The recommended dosage is one 1000 mg tablet twice daily. It is important to follow your healthcare provider’s instructions.

Indications

Ranexa 1000 tablets are indicated for the treatment of chronic angina. It helps reduce the frequency of episodes of chest pain.

Contraindications

Do not use Ranexa if you have liver cirrhosis or if you are taking strong CYP3A inhibitors. Consult your doctor for more information.

Directions

Swallow the tablet whole with water, do not crush or chew it. Take it regularly at the same times each day.

Scientific Evidence

Ranolazine, the active ingredient in Ranexa, works by inhibiting the late sodium current in cardiac cells, which helps to reduce intracellular calcium overload during ischemia. This mechanism of action results in improved oxygen utilization and reduced angina symptoms. Clinical trials have shown Ranexa to be effective in reducing angina episodes and improving exercise tolerance in patients with chronic angina.

Additional Information

Ranexa 1000 tablets with prolonged release have been well-studied in various clinical trials. One study published in the Journal of the American College of Cardiology demonstrated that ranolazine significantly reduced angina frequency and nitroglycerin use compared to a placebo. Another study in the European Heart Journal showed that ranolazine improved exercise duration and time to angina onset in patients with chronic angina. It is important to discuss with your healthcare provider if Ranexa is suitable for your condition.

• Ranolazine inhibits the late sodium current in cardiac cells.
• Clinical trials have shown Ranexa to be effective in reducing angina episodes.
• Consult your doctor before starting Ranexa to ensure it is safe and appropriate for you.